Valeant shares slide on news of probe by U.S. SEC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Wall Street ends higher as tech rebounds before Nvidia results
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
- Nvidia Q2 preview: a beat is a fail, a blowout is base case
Valeant Pharma (VRX) CEO Pearson to Hold Call with Analysts Today - Bloomberg
February 29, 2016 1:58 PM ESTValeant Pharma (NYSE: VRX) CEO Mike Pearson will hold a call with sell-side analysts later today after cancelling a public call earlier in the day, Bloomberg reported citing people families with the matter.
... MoreValeant Pharma (VRX) Twitter Bull Throws in the Towel
February 29, 2016 1:34 PM ESTA notable Valeant Pharma (NYSE: VRX) bull on Twitter appears to be throwing in the towel.
Truth about Valeant said: "Valeant is certainly giving their best impression of a house of cards on the verge of collapse. We can no longer defend this... More
